Literature DB >> 17516066

A novel mutation of -73(A-->T) in the CCAAT box of the beta-globin gene identified in a patient with the mild beta-thalassemia intermedia.

Xiao-Wei Chen1, Qiu-Hua Mo, Qiang Li, Rong Zeng, Xiang-Min Xu.   

Abstract

The beta-thalassemia is one of the most common autosomal recessive disorders in Southern China. The point mutation of beta-globin gene is the commonest molecular pathogenic mechanism. In Chinese population, over 30 mutations have now been identified. In this paper, we describe a novel beta(++)-thalassemia mutation of -73(A-->T) within the conserved CCAAT box at position -76 to -72 from the cap site of the beta-globin gene. The proband, an 8-year-old Chinese boy, was a compound heterozygote of this promoter mutation and a common beta(0)-thalassemia mutation of codon 41/42(-TCTT). He had a mild thalassemia intermedia phenotype and was transfusion independent with a hemoglobin (Hb) level of 9.4 g/dl, mean corpuscular volume (MCV) of 55.2 fl, and mean corpuscular hemoglobin (MCH) of 17.5 pg. His mother and two maternal uncles were carriers of -73(A-->T) mutation in beta-globin gene with hematological phenotype of silent beta-thalassemia. Real-time quantitative reverse transcript polymerase chain reaction (RT-PCR) analysis showed a slightly reduced beta-globin messenger RNA (mRNA) level (19.35%) in three heterozygotes compared with that in normal subjects. In restriction fragment length polymorphism (RFLP) haplotype analysis, the results indicated that this promoter mutation might be linked to the absence of BamHI-3'beta restriction site.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17516066     DOI: 10.1007/s00277-007-0312-8

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  3 in total

1.  Two novel copy number variations involving the α-globin gene cluster on chromosome 16 cause thalassemia in two Chinese families.

Authors:  Lingling Hu; Xuan Shang; Sheng Yi; Ren Cai; Zhetao Li; Cuixian Liu; Yidan Liang; Decheng Cai; Feng Zhang; Xiangmin Xu
Journal:  Mol Genet Genomics       Date:  2016-03-21       Impact factor: 3.291

2.  Human telomere disease due to disruption of the CCAAT box of the TERC promoter.

Authors:  Anna M Aalbers; Sachiko Kajigaya; Marry M van den Heuvel-Eibrink; Vincent H J van der Velden; Rodrigo T Calado; Neal S Young
Journal:  Blood       Date:  2012-02-08       Impact factor: 22.113

3.  A Novel -72 (T→A) β-Promoter Mutation Causing Slightly Elevated HbA2 in a Vietnamese Heterozygote.

Authors:  Monica Pirastru; Paolo Mereu; Chau Quynh Nguyen; Nhan Viet Nguyen; Thang Duy Nguyen; Laura Manca
Journal:  Biomed Res Int       Date:  2017-04-19       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.